(NASDAQ: TMCI) Treace Medical Concepts's forecast annual revenue growth rate of 7.95% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.22%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.66%.
Treace Medical Concepts's revenue in 2024 is $198,533,000.On average, 4 Wall Street analysts forecast TMCI's revenue for 2024 to be $12,832,358,057, with the lowest TMCI revenue forecast at $12,778,439,018, and the highest TMCI revenue forecast at $12,900,767,449. On average, 4 Wall Street analysts forecast TMCI's revenue for 2025 to be $14,119,884,997, with the lowest TMCI revenue forecast at $13,800,039,996, and the highest TMCI revenue forecast at $14,752,796,250.
In 2026, TMCI is forecast to generate $15,559,342,977 in revenue, with the lowest revenue forecast at $14,882,152,191 and the highest revenue forecast at $16,420,741,598.